Diadema Partners LP 13F holdings, Q1 2026
Holdings as of March 31, 2026 · filings on SEC EDGAR · latest filing →
Diadema Partners LP disclosed 86 US equity positions worth $242.2m in its Q1 2026 13F filing. The largest position was BRIDGEBIO PHARMA INC at 7.7% of the reported book, followed by VKTX and UTHR.
What did Diadema Partners LP own in Q1 2026? Top 50 positions
| # | Stock | Sector | Weight | Value | Shares | Δ shares | vs prior |
|---|---|---|---|---|---|---|---|
| 1 | BRIDGEBIO PHARMA INC | 7.7% | $18.6m | 250,000 | – | ||
| 2 | VKTX VIKING THERAPEUTICS INC | Healthcare | 7.1% | $17.1m | 525,181 | – | |
| 3 | UTHR UNITED THERAPEUTICS CORP DEL | Healthcare | 6.7% | $16.2m | 27,303 | – | |
| 4 | JNJ JOHNSON & JOHNSON | Healthcare | 5.4% | $13.1m | 53,771 | – | |
| 5 | COGT COGENT BIOSCIENCES INC | Healthcare | 5.1% | $12.4m | 322,764 | – | |
| 6 | JAZZ JAZZ PHARMACEUTICALS PLC | Healthcare | 4.3% | $10.4m | 54,755 | – | |
| 7 | 430 TERNS PHARMACEUTICALS INC | 4.0% | $9.6m | 181,752 | – | ||
| 8 | BMRN BIOMARIN PHARMACEUTICAL INC | Healthcare | 3.5% | $8.4m | 148,229 | – | |
| 9 | ABVX ABIVAX SA | Healthcare | 3.4% | $8.2m | 75,944 | – | |
| 10 | RVMD REVOLUTION MEDICINES INC | Healthcare | 3.2% | $7.9m | 80,872 | – | |
| 11 | KOD KODIAK SCIENCES INC | Healthcare | 3.0% | $7.4m | 192,962 | – | |
| 12 | INCY INCYTE CORP | Healthcare | 3.0% | $7.3m | 78,029 | – | |
| 13 | TGTX TG THERAPEUTICS INC | Healthcare | 2.8% | $6.9m | 206,928 | – | |
| 14 | BBIO BRIDGEBIO PHARMA INC | Healthcare | 2.6% | $6.3m | 85,311 | – | |
| 15 | IMCR IMMUNOCORE HLDGS PLC | Healthcare | 2.4% | $5.8m | 193,189 | – | |
| 16 | LLY ELI LILLY & CO | Healthcare | 2.3% | $5.5m | 6,000 | – | |
| 17 | ABBV ABBVIE INC | Healthcare | 2.2% | $5.2m | 24,058 | – | |
| 18 | RCUS ARCUS BIOSCIENCES INC | Healthcare | 2.1% | $5.1m | 238,142 | – | |
| 19 | CRBP CORBUS PHARMACEUTICALS HLDGS | Healthcare | 1.7% | $4.1m | 439,957 | – | |
| 20 | CRVS CORVUS PHARMACEUTICALS INC | Healthcare | 1.5% | $3.6m | 244,811 | – | |
| 21 | ZYME ZYMEWORKS INC | Healthcare | 1.5% | $3.6m | 142,132 | – | |
| 22 | GPCR STRUCTURE THERAPEUTICS INC | Healthcare | 1.4% | $3.5m | 72,234 | – | |
| 23 | GLUE MONTE ROSA THERAPEUTICS INC | Healthcare | 1.3% | $3.1m | 187,307 | – | |
| 24 | TENX TENAX THERAPEUTICS INC | 1.2% | $2.9m | 179,738 | – | ||
| 25 | HRMY HARMONY BIOSCIENCES HLDGS IN | Healthcare | 1.1% | $2.6m | 92,864 | – | |
| 26 | CAPR CAPRICOR THERAPEUTICS INC | Healthcare | 1.0% | $2.4m | 78,851 | – | |
| 27 | EYPT EYEPOINT INC | Healthcare | 1.0% | $2.3m | 178,545 | – | |
| 28 | BCYC BICYCLE THERAPEUTICS PLC | Healthcare | 0.9% | $2.2m | 476,424 | – | |
| 29 | INDV INDIVIOR PHARMACEUTICALS INC | Healthcare | 0.9% | $2.2m | 71,376 | – | |
| 30 | CLYM CLIMB BIO INC | Healthcare | 0.8% | $2.0m | 286,126 | – | |
| 31 | IVA INVENTIVA SA | 0.8% | $1.9m | 352,399 | – | ||
| 32 | STTK SHATTUCK LABS INC | Healthcare | 0.8% | $1.9m | 293,664 | – | |
| 33 | TARS TARSUS PHARMACEUTICALS INC | Healthcare | 0.8% | $1.8m | 25,942 | – | |
| 34 | ALKS ALKERMES PLC | Healthcare | 0.7% | $1.8m | 50,000 | – | |
| 35 | MGNX MACROGENICS INC | Healthcare | 0.7% | $1.7m | 600,000 | – | |
| 36 | VRTX VERTEX PHARMACEUTICALS INC | Healthcare | 0.7% | $1.7m | 3,840 | – | |
| 37 | VYGR VOYAGER THERAPEUTICS INC | Healthcare | 0.7% | $1.6m | 423,642 | – | |
| 38 | PCVX VAXCYTE INC | Healthcare | 0.6% | $1.5m | 25,071 | – | |
| 39 | RLMD RELMADA THERAPEUTICS INC | Healthcare | 0.6% | $1.4m | 200,842 | – | |
| 40 | BIOA BIOAGE LABS INC | 0.4% | $1.0m | 60,000 | – | ||
| 41 | INO INOVIO PHARMACEUTICALS INC | 0.4% | $979.0k | 562,665 | – | ||
| 42 | AYTU AYTU BIOPHARMA INC | 0.4% | $963.9k | 353,077 | – | ||
| 43 | EQ EQUILLIUM INC | 0.4% | $867.7k | 433,844 | – | ||
| 44 | DNTH DIANTHUS THERAPEUTICS INC | Healthcare | 0.3% | $839.2k | 10,000 | – | |
| 45 | PHVS PHARVARIS N V | Healthcare | 0.3% | $828.3k | 29,321 | – | |
| 46 | ENTA ENANTA PHARMACEUTICALS INC | Healthcare | 0.3% | $820.3k | 64,952 | – | |
| 47 | REPL REPLIMUNE GROUP INC | Healthcare | 0.3% | $770.0k | 100,660 | – | |
| 48 | XERS XERIS BIOPHARMA HOLDINGS INC | Healthcare | 0.3% | $769.9k | 132,746 | – | |
| 49 | LRMR LARIMAR THERAPEUTICS INC | Healthcare | 0.3% | $749.9k | 166,637 | – | |
| 50 | ANNX ANNEXON INC | Healthcare | 0.3% | $736.4k | 132,916 | – |
Weights are shares of the reported long US equity book (options excluded). Values are as filed, normalised to whole dollars. Share changes compare against the immediately preceding filing only.